Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transdermal methods and systems for the delivery of anti-migraine compounds

Transdermal methods and systems for the delivery of anti-migraine compounds

US Patent 9272137 · Granted Mar 1, 2016

Estimated economic value: $279,703,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of behavioral impairment in developmental and epileptic encephalopathy2025
Treatment of fragile X syndrome with cannabidiol2025
Treatment of autism with cannabidiol2025
Treatment of 22Q11.2 deletion syndrome with cannabidiol2025
Treatment of Fragile X Syndrome with cannabidiol2023
Treatment of 22Q11.2 deletion syndrome with cannabidiol2022
Treatment of Fragile X Syndrome with cannabidiol2022
Abuse potential reduction in abusable substance dosage form2022
Abuse potential reduction in abusable substance dosage form2022
Treatment of fragile x syndrome with cannabidiol2020
Treatment of autism with cannabidiol2020
Treatment of fragile X syndrome with cannabidiol2019